A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2537057
The present invention relates to an in vivo regimen for the treatment of a proliferative disease, preferably a tumor that is refractory to treatment with one or more chemotherapeutics other than a epothilone, where an epothilone is administered in a loading dose followed by at least 1 maintenance dose.
L'invention concerne un schéma posologique in vivo permettant de traiter une maladie proliférative, de préférence une tumeur réfractaire à un traitement faisant appel à un ou plusieurs agent(s) chimiothérapeutique(s) autre(s) qu'une épothilone. Selon l'invention, une épothilone est administrée en une dose d'attaque suivie d'au moins une dose d'entretien.
Dilea Clifford
Maira Sauveur-Michel
Mcsheehy Paul M. J.
Tanaka Chiaki
Wartmann Markus
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Cancer treatment with epothilones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer treatment with epothilones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer treatment with epothilones will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724916